The article reports on the failure of various drugs which were designed to treat neuron disorder after so many drug trials on various people. Canada-based NoNO company has developed a neuroprotective compound called NA-1, a cell-permeable peptide that blocks the formation of a free radical in the brain called nitric oxide (NO). The company is looking for partners to advance the company's drug into larger trials.